May 5, 2020
Securities and Exchange Commission
Division of Corporation Finance
100 F Street N.E.
Washington, D.C. 20549
| Attention: | Division of Corporation Finance, | |
| Office of Life Sciences |
VIA EDGAR
| Re: | Medigus Ltd. (the “Company”) | |
| Registration Statement on Form F-3 (the “Registration Statement”) | ||
| Filed on April 21, 2020 | ||
| File No. 333-237774 |
Dear Madam or Sir:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company respectfully requests that the effectiveness of the registration statement on Form F-3 (File No. 333-237774) of the Company (the “Registration Statement”) be accelerated so that the Company’s Registration Statement will become effective at 04:00 p.m., Eastern Time, on May 5, 2020 or as soon thereafter as may be practicable.
The undersigned respectfully requests that it be notified of the effectiveness of the Registration Statement by email to our counsel, Meitar Law Offices, by emailing Dr. Shachar Hadar, Esq. at shacharh@meitar.com and Jonathan M. Nathan, Esq. at jonathann@meitar.com.
| Sincerely, | |
| /s/ Liron Carmel | |
Liron Carmel Medigus Ltd. |